|
KTTA Pasithea Therapeutics Corp 1841330 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-2,869,482.00 |
| Balance Sheet |
|
Current Assets
|
$52,731,456.00 |
|
Assets
|
$56,354,901.00 |
|
Current Liabilities
|
$1,489,485.00 |
|
Liabilities
|
$1,542,451.00 |
|
Equity
|
$54,812,450.00 |
|
Shares Out
|
24939948.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-4,787,220.00 |
|
Investing Cash Flow
|
$11,000.00 |
| Market Analysis |
Market Cap
|
$10,973,577.12 |
|
Price
|
$0.44 |
|
BVPS
|
2.20 |
|
PB
|
0.20 |
|
EPS
|
-0.12 |
|
FCF
|
$-5,787,220.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:43 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:43 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view KTTA documents filed with the SEC.
KTTA Filings
Clear
